For many years, the high-affinity receptor for immunoglobulin E (IgE) FceRI, which is expressed by mast cells and basophils, has been widely held to be the exemplar of cross-linking (that is, aggregation dependent) signaling receptors. We found, however, that FceRI signaling could occur in the presence or absence of receptor cross-linking. Using both cell and cell-free systems, we showed that FceRI signaling was stimulated by surfaceassociated monovalent ligands through the passive, size-dependent exclusion of the receptor-type tyrosine phosphatase CD45 from plasma membrane regions of FceRI-ligand engagement. Similarly to the T cell receptor, FceRI signaling could also be initiated in a ligand-independent manner. These data suggest that a simple mechanism of CD45 exclusion-based receptor triggering could function together with cross-linking-based FceRI signaling, broadening mast cell and basophil reactivity by enabling these cells to respond to both multivalent and surface-presented monovalent antigens. These findings also strengthen the case that a size-dependent, phosphatase exclusion-based receptor triggering mechanism might serve generally to facilitate signaling by noncatalytic immune receptors.
INTRODUCTION
The high-affinity immunoglobulin E (IgE) receptor, FceRI, sensitizes mast cells and basophils to IgE-targeted antigens, thus underpinning both antiparasite and allergic responses (1) . FceRI comprises a tetrameric complex consisting of the IgE-binding chain, FceRIa, associated with FceRIb and a covalent FceRIg homodimer (2) . Binding of cognate antigen by FceRI-bound IgE induces rapid phosphorylation of immunoreceptor tyrosine-based activation motifs (ITAMs) in the cytoplasmic domains of FceRIb and FceRIg by the Src family kinase (SFK) Lyn (3), enabling recruitment and activation of spleen tyrosine kinase (Syk) through interactions of its Src homology 2 (SH2) domains with the phosphorylated ITAMs of FceRIg (4) . Activated Syk then initiates a signaling cascade through phospholipases and calcium (Ca 2+ ) mobilization that ultimately leads to the exocytosis of proinflammatory granules containing, for example, histamine (1) .
For many years, IgE-initiated signaling was considered to be the quintessential example of aggregation-driven immunoreceptor triggering (5) . Very early studies suggested that, for IgE-mediated exocytosis, intermolecular cross-linking of cell-bound antibody was required for signaling (6) . Accordingly, it was shown that multivalent antigens were generally capable of eliciting mast cell responses, whereas univalent, monomeric ligands were not. It was also shown that cross-linking did not necessarily have to be antigen mediated; bivalent anti-IgE antibody (7) or artificially aggregated IgE, or the Fc fragments of IgE, were all found to be active (8) . It was subsequently proposed that dimers of IgE serve as a minimal signaling "unit" for mast cell degranulation (9) , albeit weakly (10, 11) . The current view is that, for FceRI to be triggered, the receptor must be cross-linked by multivalent antigens to achieve the necessary density and geometry required for receptor transphosphorylation by FceRI-associated Lyn (3, 12) . Alternatively, cross-linking-based aggregation might induce changes in the distribution of FceRI within membrane domains that protect it from dephosphorylation (13, 14) . Irrespective of the mechanism, constraining FceRI reactivity to multivalent antigens would have the effect of severely restricting the breadth of mast cell and basophil responses.
Despite the enduring appeal of aggregation-based signaling, it was quickly realized that it created a paradox because antibody receptors were understood to be expressed at sufficiently high amounts, and enough of them are mobile, for dimers to form on a purely stochastic basis; however, spontaneous exocytosis is not observed (5) . Further findings have produced new difficulties. The binding of free IgE to mast cells influences numerous cellular responses, including cytokine production, cell survival and differentiation, and FceRI expression (15) (16) (17) , implying that FceRI is capable of sensing IgE in an aggregation-independent manner. These effects are, however, distinct from those of so-called "highly cytokinergic" IgEs, which induce degranulation at very high concentrations, most likely through receptor cross-linking by surface-expressed autoantigens (18) . In addition, FceRI expressed in transfected fibroblasts is spontaneously phosphorylated (19) , revealing that aggregation per se is not a strict requirement of receptor triggering, but most importantly, mast cell degranulation is robustly triggered by monovalent antigens attached to supported lipid bilayers (SLBs) (20, 21) . Similar to a second immune receptor, that is, the B cell receptor (22) , which was also widely assumed to be triggered only by cross-linking but is now known to be reactive to surface-presented monovalent ligands, it is now accepted that FceRI can be triggered by both monovalent and multivalent antigens.
Alongside these findings, it is becoming recognized that the properties of many common allergens are incompatible with, or at least seem unsuited to, aggregation-based FceRI triggering in vivo. First, many known allergens are monomeric [e.g., (23) (24) (25) (26) ]. These could cross-link FceRI in the presence of polyclonal IgE against nonoverlapping epitopes, but this would only work within a narrow range of binding geometries according to studies of model antigens (11) . Second, most dimeric allergens that self-associate only do so transiently (27) , with reported dissociation constant (K d ) values in the micromolar to millimolar range (28, 29) . Because exposure to common animal allergens is typically <1 to 300 ng/day (30, 31) , which corresponds to~0.02 to 8 pmol/day for the major cat allergen Fel d 1, and pollen allergens are encountered at 10-to 100-fold lower amounts (31, 32) , these types of allergens will most likely be presented to mast cells and basophils as monomers, unless they accumulate in allergen-sensitive tissues.
Intrigued initially by differences in the functionality of surface-exposed and nonexposed mast cells, we explored the surface dependence of FceRI signaling. We found that FceRI was triggered by surfaces lacking FceRI ligands, accounting for the characteristic behavior and morphology of basophilic cells in vitro. We then showed that signaling occurred in both the presence and absence of receptor aggregation and that it was robustly triggered by surface-associated monovalent ligands through the passive, size-dependent exclusion of the large receptor-type protein tyrosine phosphatase CD45 from regions of contact of FceRI with its ligands. Whereas previous work suggested that CD45 exclusion and FcgR signaling are dependent on integrins forming an actin-tethered diffusional barrier to the phosphatase (33), we observed strong signaling by FceRI in the absence of integrin activity and spontaneous phosphatase exclusion from engaged receptors in both cells and cell-free systems. We propose that a phosphatase exclusion-based mechanism functions alongside aggregation-driven receptor triggering to broaden the reactivity of mast cells. In this way, we propose that the paradoxical features of FceRI triggering can be reconciled.
RESULTS

Mast cells sense the presence of surfaces
In the course of culturing rat basophilic leukemia (RBL) 2H3 cells, we observed small but statistically significant differences in FceRI phosphorylation in cells kept in suspension by gentle end-overend rotation versus those allowed to make contact with plastic surfaces [ Fig. 1 , A (left) and B]. FceRI phosphorylation was detected on Western blots, using an antipY47 FceRIg phospho-specific antibody (34) , as pairs of bands corresponding to short-and long-lived, mono-and dualphosphorylated forms of FceRIg. We tested whether this was due to surface contact per se by quantifying phosphorylated FceRIg as the cells settled onto plastic surfaces in phosphatebuffered saline (PBS). The degree of phosphorylation was expressed as the ratio of dual-phosphorylated FceRIg intensity to total receptor intensity, normalized to the ratio of intensities measured in cells activated with anti-trinitrophenol (TNP) IgE and soluble TNP-conjugated flux responses within 10 min of making contact with uncoated glass ("glass") or PLL-coated glass. For all bar graphs, data are means ± SD of three independent experiments. Blots and images are representative of three independent experiments. Scale bars, 5 mm. *P < 0.05, **P < 0.01, ***P < 0.001; ns, not significant. bovine serum albumin (TNP BSA ) as antigen. A small, time-dependent increase in FceRIg phosphorylation was observed as the cells settled, peaking at 5 to 10 min [ Fig. 1, A (right) and B]. These results indicated that RBL-2H3 cells, as they are usually grown, are not "resting" with respect to FceRI phosphorylation direct from tissue culture.
Using interference reflection and contrast microscopy to visualize cell contact areas and morphologies after adherence to microscope cover glass, we examined in more detail the effects of cell cultureinduced FceRI signaling in wild-type (WT) RBL-2H3 cells and RBL-2H3 cells lacking FceRIa ("FceRI−ve" cells), which were generated using CRISPR-Cas9 mutagenesis ( fig. S1A ) (35) , under conditions that facilitated imaging. WT RBL-2H3 cells that attached to uncoated glass in fetal calf serum (FCS)-supplemented growth medium formed statistically significantly larger contacts after 30 min than did FceRI−ve cells, whose contacts were similar to those of RBL-2H3 cells treated with the SFK inhibitor PP2 (Fig. 1, C and D) . The contact areas formed by WT cells were not affected by the presence of FCS or by preloading with IgE ( fig. S1B ). Normal contact size was restored for FceRI−ve cells by reintroduction of FceRIa ("FceRI+ve" cells; Fig. 1 , C and D, and fig. S1A ). Surface-grown WT RBL-2H3 cells exhibited more dendritic morphology (that is, they had protrusions extending away from the main cell body) than did FceRI−ve cells (Fig. 1, E and F) . Under normal culture conditions, RBL-2H3 cells grew predominantly as an adherent monolayer. However, substantially more FceRI−ve cells grew in suspension compared to WT RBL-2H3 cells (Fig. 1G) , and the surface-attached cells were more easily detached (Fig. 1H) . FceRI−ve RBL-2H3 cells were, however, as motile as WT cells ( fig. S1C ). Poly-L-lysine (PLL)-coated surfaces induced RBL-2H3 cells to form large contacts in an FceRI-independent manner (Fig. 1I) , although FceRI−ve cells formed statistically significant, albeit slightly smaller, contacts compared to those of WT cells. Robust Ca 2+ signaling was observed for WT and FceRI+ve cells, but not for FceRI−ve cells, upon contact with PLL-coated glass (Fig. 1J) , suggesting that this surface led to FceRI triggering, similar to the case of T cells and the T cell receptor (TCR) (36) . PLL also induced substantial FceRIg phosphorylation in RBL-2H3 cells and primary human basophils (fig. S1, D to F). Together, these data suggest that mast cells sense surfaces through FceRI signaling, a consequence of which might be the characteristic, adherent nature of cultured RBL-2H3 cells. That PLL induced strong signaling was an initial indication that FceRI signaling was not dependent on integrin mobilization.
FceRI is triggered by immobilized ligands and sensitive to constitutive kinase and phosphatase activity The capacity of FceRI to be triggered without cognate ligands after contact with a surface was reminiscent of the TCR (37) and further undermined the aggregation-only theory of FceRI signaling. To revisit its actual requirements, we used the classical approach to studying aggregation-based FceRI signaling (12) , that is, BSA-coupled hapten (TNP BSA ) and anti-TNP IgE in solution and adsorbed onto glass. We also generated an artificial, monovalent FceRI ligand mimic (His-Fce), comprising the C H 2 to C H 4 domains of rat Fce preceded by an N-terminal His 12 -tag, which we could present in an FceRI-accessible orientation ( fig. S2A ) on Ni-coated glass surfaces (mimicking monovalent immobilized antigens) or SLBs (to mimic mobile, cell-presented monovalent ligands). We used Ca 2+ signaling as a proxy for receptor triggering. Previous work showed that soluble monovalent antigen does not trigger FceRI signaling, whereas when it is attached in a mobile form to an SLB, the same antigen induces RBL-2H3 degranulation (20, 21).
As expected, therefore, RBL-2H3 cells did not produce measurable Ca 2+ responses to soluble His-Fce or to Ni-coated glass that did not present His-Fce ( Fig. 2A) . However,~80% of cells produced detectable responses within 10 min of making contact with SLBs presenting His-Fce ( Fig. 2A) , with an average delay between surface contact and triggering of 217 s. Equivalent fractions of the cell population produced Ca 2+ responses within 10 min of contact with surfaces coated with TNP BSA -IgE or with His-Fce, as did cells exposed to anti-TNP IgE followed by soluble TNP BSA (Fig. 2A) . The consistency of the triggering fraction likely reflects the overall number of responsive cells. Nonetheless, phosphorylated FceRIg was somewhat more abundant in cells after contact with immobilized, cross-linked IgE than in cells exposed to immobilized monovalent ligand mimics (Fig. 2B) . Soluble, cross-linked ligand produced the largest effect (normalized value of 1 in Fig. 2B ), likely because it engaged more of the surface FceRI than did any of the immobilized ligands. These observations indicate that, like the TCR, FceRI can be triggered by receptorclustering and surface-associated monovalent ligands.
We sought to establish whether, also like the TCR (38) (39) (40) (41) , FceRI is sensitive to the constitutive activities of kinases and phosphatases in situ. FceRIg phosphorylation was induced in RBL-2H3 cells and primary human basophils by the tyrosine phosphatase inhibitor, pervanadate (Fig. 2, C and D, and fig. S2B ). However, receptor cross-linking resulted in greater amounts of phosphorylated FceRIg than were induced by pervanadate, implying that local kinase activity was enhanced by receptor clustering. Near-complete inhibition of FceRI phosphorylation was observed if the SFK inhibitor PP2 was added 15 min before pervanadate, but not 15 min afterward. These results indicate that, in resting cells, and especially in resting primary basophils in which the spontaneous, PP2-inhibited abundance of phosphorylated FceRIg was relatively high (Fig. 2D and fig. S1 , E and F), FceRI is accessible to active SFKs, but its phosphorylation is constrained by constitutive tyrosine phosphatase activity. These observations are inconsistent with the notion that inactive FceRIg is in some way sequestered away from phosphatases (13, 14) .
CD45 and FceRI segregate after engagement by surface-associated IgE
The dependence of FceRI triggering on the surface attachment of monovalent ligands and the sensitivity of the receptor to constitutively active kinases and phosphatases suggested that FceRI might be triggered by local, size-dependent phosphatase exclusion. We (37) and others (33, 42) have reported that CD45 is excluded from contacts that leukocytes form with model surfaces. We previously proposed that ligand-induced receptor triggering arises in vivo if receptors, such as the TCR, are held in phosphatase-depleted contacts by ligands, favoring phosphorylation of the receptors [the "kinetic-segregation" model] (43) .
To test whether phosphatase exclusion accompanies the engagement of FceRI by ligands, we studied the behavior of CD45, which is expressed by mast cells and regulates FceRI activity through both inhibitory and activatory effects (44, 45) . Basal surfaces of RBL-2H3 cells were imaged by confocal microscopy, detecting FceRI, CD45RO (the shortest CD45 isoform), and Syk, which were tagged with SNAP-tag, HaloTag, and citrine, respectively. For all activating surfaces, that is, His-Fce on Ni glass or SLBs, and TNP BSA -IgE on glass, CD45 was excluded from areas containing FceRI and Syk within 10 to 20 s of cell contact, forming exclusion zones that were 1 to 2 mm in diameter (Fig. 3 , A to C, and movie S1; additional example images are shown in fig. S3 ). Recruitment of citrine-labeled Syk to regions of FceRI accumulation ( fig. S4A ), similarly to the recruitment of ZAP70 to the TCR (37), was taken to be evidence of receptor triggering and phosphorylation. Photobleaching analysis showing loss of the citrine signal ( fig. S4B ) confirmed that Syk was localized at the membrane in FceRI-enriched but not CD45-enriched areas. Cells interacting with immobile ligands (His-Fce on Ni glass and TNP BSA -IgE on glass) formed stably organized contacts that expanded as the cells spread (Fig. 3 , A and C). For TNP BSA -IgE, this led to the formation of a complex network of mutually exclusive CD45-and FceRI/Syk-enriched zones after 5 min (Fig. 3A, bottom) . CD45 exclusion from FceRI-enriched regions was also observed in cells preloaded with anti-TNP IgE before making contact with TNP BSA -coated glass ( fig. S4C ). For cells activated on His-Fce-presenting SLBs (Fig. 3B) , the initial contacts led to synapse formation within~5 min, as reported previously (20) , in which CD45 was excluded to the peripheral regions of the contact. CD45 was also excluded from the basal plane of cells cultured on coverslips in the absence of ligand (Fig. 3D) , consistent with the greater abundance of phosphorylated FceRIg in resting RBL-2H3 cells grown in adherent versus suspension culture (Fig. 1, A and B) . Similarly, CD45 and FceRI were excluded from FceRI-enriched regions when cells made contact with PLL-coated coverslips (Fig. 3E ) but more so in the case of CD45, which may account for the signal-potentiating effects of PLL (Fig. 1J) . Primary human basophils that made contact with coverslips coated with the common dust mite antigen Der f 1 exhibited exclusion of CD45 from FceRI-enriched regions if they were first loaded with antiDer f 1 human IgE (hIgE) ( 
CD45 exclusion is passive
The observed segregation of CD45 and FceRI could, in principle, be a result of signaling or effected by surface contact alone. On TNP BSAIgE-coated glass, we observed the exclusion of CD45 from FceRIcontaining regions of contact in PP2-treated RBL-2H3 cells (Fig. 4A  and fig. S5A ), in which signaling was completely blocked (Fig. 4B) . To confirm that CD45 exclusion was entirely passive, we examined the behavior of the tagged proteins in giant plasma membrane vesicles (GPMVs) (46) derived from RBL-2H3 cells. GPMVs lack cytoskeletal structures and lose normal cellular energy homeostasis but retain the membrane lipid and protein compositions of the cells from which they are derived. GPMVs produced from RBL-2H3 cells presenting fluorescently tagged FceRI, CD45, and Syk formed regions of contact upon settling on either TNP BSA -IgE-coated glass or SLBs presenting His-Fce that were marked by the local exclusion of CD45RO and accumulation of FceRI ( Fig. 4C and fig. S5B ). These observations suggest that the exclusion of CD45 from contacts as they form is an entirely passive process.
Integrins are not required for CD45 exclusion or FceRI triggering
Previous work on FcgR signaling in macrophages suggested that integrin activation is needed to generate a diffusional barrier that excludes CD45 from the receptor, leading to signaling (33) . We tested whether this applied to FceRI signaling in mast cells using chemical and genetic interventions. We observed very efficient exclusion of CD45 from regions of contact of RBL-2H3 cells with TNP BSA -IgEcoated glass in the absence of free divalent cations, that is, after treatment with 1.5 mM EDTA in the absence of Ca 2+ or Mg
2+
, which abrogates the ligand binding activity of integrins ( For all bar graphs, data are means ± SD of three independent experiments, unless stated otherwise. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
integrins present (49) , had no effect on the exclusion of CD45 from contacts formed with TNP BSA -IgE-coated glass (Fig. 4E) fig. S6F ), and removal of divalent cations had no effect on FceRIg phosphorylation in primary basophils in response to Der f 1 (Fig. S6G) .
Although integrins did not appear to contribute directly to CD45 exclusion or early signaling detected as Ca 2+ fluxes, RBL-2H3 cells adhering to immobilized integrin ligands exhibit stronger degranulation and phospholipase activity than those on passivated surfaces (50, 51) . FceRI triggering by surfacebound antigen could conceivably be enhanced by integrin-mediated interactions that stabilize or increase the size of surface contacts, lowering the threshold for signaling. We tested whether RBL-2H3 cells were more sensitive to TNP BSA -IgE in the presence of a peptide derived from rat laminin, which promotes mast cell surface attachment (52) by binding to CD29 in complex with a integrin subunits, such as CD49f (53, 54) . Ca 2+ responses ( Fig. 4G and  fig. S6C ) and the amount of phosphorylated FceRIg ( fig. S6F ) in cells that made contact with laminin peptide-coated surfaces were comparable to those observed in cells in the absence of laminin, suggesting that, at least for initial receptor signaling, there is little contribution from CD29.
Size-based CD45 exclusion drives FceRI signaling A likely cause of CD45 exclusion from regions of FceRI engagement is the difference in size of IgE-receptor complexes and CD45. This is because the extracellular region of CD45RO is 216 Å (37) , and the complex formed by the extracellular region of FceRI and IgE measures~100 Å along an axis orthogonal to the plane of the plasma membrane (55) . We tested this assertion by generating size-variant IgE ligand mimics composed of the short His-Fce construct and incorporating either one or three copies of the human CD43 extracellular domain (amino acid residues 20 to 254) between the histidine tag and Fce (generating CD43 1 Fce and CD43 3 Fce; Fig. 5A ). Like His-Fce, these proteins bound to FceRI with stabilities comparable to those of rat IgE ( fig. S2, C and D) . However, the relatively rigid CD43 domains (56) were expected to force FceRI to engage Fce further from the SLB surface, reducing the effect of ligand engagement on size-dependent reorganization of kinases and phosphatases.
In contrast to the efficient exclusion observed on His-Fce-coated surfaces (Fig. 3 , B and C), CD45 exclusion was not observed in RBL-2H3 cells that made contact with surfaces presenting either mobile or immobile CD43 1 Fce or CD43 3 Fce (Fig. 5 , B and C). Fewer RBL-2H3 cells produced Ca 2+ calcium responses after contacting CD43 1 Fce-or CD43 3 Fce-functionalized surfaces compared to cells that interacted with His-Fce (Fig. 5D) ; there was no measurable difference between the behaviors of cells that interacted with CD43 1 Fce or CD43 3 Fce. CD45 was excluded from contacts formed by freshly isolated (hIgEbound) primary human basophils with glass coated with mouse anti-hIgE (Fig.  5E ), and much less exclusion when the basophil-surface "gap" was increased by coating the anti-hIgE indirectly onto the surface using donkey anti-mouse IgG ( fig. S6H ), despite the densities of antihIgE being comparable ( fig. S6I ). Moreover, primary basophils that interacted with a surface coated with anti-hIgE had an increased abundance of phosphorylated FceRI than did cells that made contact with anti-hIgE/anti-mouse IgG-coated glass (Fig. 5F ).
These observations suggest that FceRI is triggered by CD45 exclusion, at least for surfaces presenting compact FceRI ligands, that is,~100 Å, the size of His-Fce. Whereas we relied heavily on Ca 2+ signaling as a reporter of FceRI triggering per se, it seemed possible that the extent of signaling we observed due to CD45 exclusion comprised a background or subthreshold response that was insufficient to trigger the important effector functions of mast cells. We therefore tested whether mast cell degranulation in response to surface-presented antigens is also dependent on phosphatase exclusion. We observed that mast cell degranulation was no greater than background levels for the CD43 1 Fce and CD43 3 Fce ligand mimics presented in either mobile or immobile forms (Fig. 5G) . Immobile His-Fce induced about threefold greater degranulation than did mobile His-Fce, perhaps due to the contactstabilizing effects of glass-bound Ni 2+ in the manner of PLL (36) .
FceRI triggering relies on the large extracellular domain of CD45 As a final test of the sensitivity of FceRI to local, size-based exclusion of CD45, we tested whether signaling was dependent on the size of CD45 itself, as in the case of TCR-driven signaling (57, 58) . We stably transfected RBL-2H3 cells with plasmids expressing chimeric forms of CD45 consisting of the transmembrane and intracellular regions of rat CD45 and the extracellular domains of either CD43 or CD86 (generating CD43CD45 and CD86CD45, respectively). CD43 has a mucin-like extracellular domain comparable in size to those of the longer CD45 isoforms (~400 Å) (56), whereas CD86 is much shorter (~75 Å; Fig. 6A ) (59) . After expression in RBL-2H3 cells, each form of CD45 was detected through a C-terminal HaloTag, together with FceRI labeled with a SNAP-tag, and Syk tagged with citrine. As observed for CD45RO (Fig. 3D ), CD43CD45 exhibited partial exclusion from FceRI-enriched regions on the basal surface of cells cultured on glass for 24 hours, whereas CD86CD45 did not (Fig. 6, B and C) . Measurement of the local concentration of CD45 molecules by fluorescence correlation spectroscopy indicated that there was three-to fourfold depletion of CD45RO and CD43CD45 from the basal surface relative to the apical surface, whereas CD86CD45 was equally distributed at both sites (Fig. 6D) .
Truncation of its extracellular domain altered the distribution of CD45 on activating surfaces. CD43CD45, but not CD86CD45, was excluded from FceRI-enriched regions on TNP BSA -IgEcoated glass, to an extent comparable to that of CD45RO (Fig. 6, E to G; fig. S7 , A and G; and movie S3). The ratio of CD45 fluorescence outside versus inside regions of FceRI fluorescence was~1 for CD86CD45 and >1 for CD45RO and CD43CD45 (Fig. 6F) . CD43CD45, which is larger than CD45RO, was slightly more excluded (Fig. 6F) . Mast cells typically express CD45 isoforms larger than CD45RO (60), and so, native CD45 segregation may be more efficient than that we observed. Transfection of RBL-2H3 cells with vector expressing CD86CD45 reduced the number of cells producing Ca 2+ responses within 10 min of making contact with either mobile or immobile Replicates with primary basophils were performed with blood from different donors. Scale bars, 5 mm. *P < 0.05, ***P < 0.001, ****P < 0.0001. , and CD43CD45 after making contact for the indicated times with Ni-coated glass functionalized with His-Fce (top) or with TNP BSA -IgE-coated glass (bottom). Data are means ± SD of three independent experiments. All images are representative of observations made in at least three independent experiments. Scale bars, 5 mm. *P < 0.05, **P < 0.01, ***P < 0.001.
His-Fce by about twofold versus CD45RO-or CD43CD45-expressing cells (Fig. 6H) . Although the fraction of responding cells was unaffected by CD86CD45 for cells that made contact with TNP BSA -IgE-coated glass (Fig. 6H) , the triggering lag time was statistically significantly increased ( fig. S7 , C to E). CD86CD45-expressing cells also exhibited a reduced abundance of phosphorylated FceRIg upon making contact with His-Fce, but not with TNP BSA -IgE (Fig. 6I) , and were less efficient at degranulation ( fig. S7B) . Expression of CD86CD45 but not of CD43CD45 also reduced cell adhesion strength, suggestive of reduced basal FceRI triggering ( fig. S7F ).
FceRI is triggered by unilamellar vesicles
To confirm that signaling could, in principle, be driven by passive phosphatase exclusion alone, we tested whether signaling was initiated by unilamellar vesicles presenting FceRI ligand mimics. Both large and giant unilamellar vesicles (LUVs and GUVs) enable ligand mimics to be presented under conditions more reflective of the membrane curvature and lower resistance to deformational forces of cells versus SLBs (61) . GUVs are similar in size to or smaller than whole cells but mimic cell-cell associations, whereas LUVs are typically smaller than 2 mm in diameter and so more closely replicate interactions with smaller structures, for example, fragments of opsonized cells or large allergens, such as pollen grains, or microvilli. Both exclusion of CD45 and enrichment of FceRI and Syk were observed at contacts between RBL-2H3 cells and either GUVs or LUVs loaded with His-Fce (Fig. 7A) . Exclusion of CD45 was once again impaired either by truncation of its extracellular domain or by extension of the His-Fce ligand mimic ( fig. S7H ). In both cases, Syk recruitment was reduced accordingly, despite the accumulation of comparable amounts of FceRI.
DISCUSSION
For more than 40 years, FceRI triggering was considered to be adequately explained by ligand-induced receptor aggregation; however, more recent findings have challenged this view. Principal among these is the observation that some of the best-studied allergens are monovalent [e.g., (23, 24) ] and that monovalent ligands provoke vigorous mast cell activation when immobilized on model surfaces (20, 21) . Here, we showed that, in the first instance, FceRI phosphorylation was kept under tonic control by the local balance of kinase and phosphatase activities, which are affected by various factors in addition to receptor aggregation. In this context, the ability of surface-immobilized, monovalent ligands to induce signaling can be explained simply by the exclusion of large phosphatases from regions of FceRI-ligand engagement. Supporting this view, we went on to show (i) that CD45 was excluded at sites of ligand engagement and Syk recruitment (that is, sites of receptor phosphorylation) after RBL-2H3 cells and primary basophils made contact with ligand-presenting surfaces; (ii) that this effect was size dependent, that is, that CD45 exclusion and signaling were each abrogated either by increasing the size of the ligand or by reducing the size of the extracellular domain of CD45; (iii) that preventing CD45 exclusion from FceRI-enriched regions inhibited triggering and degranulation in response to monovalent, surface-associated ligands; and (iv) that the exclusion of CD45 was entirely passive, that is, it occurred both in the absence of signaling in intact cells and spontaneously in GPMVs devoid of any active metabolism or adenosine 5′-triphosphate. The strongest argument that signaling does not only depend on ligand-driven FceRI aggregation is that we observed strong activation of RBL-2H3 cells and primary human basophils on surfaces coated with PLL, which appears only to be capable of immobilizing receptors and efficiently excluding CD45 from regions of contact (36) . We, and others, have shown that the TCR can be triggered by the passive, size-dependent exclusion of inhibitory phosphatases from sites of ligand engagement (37, 43, 62) . Our findings here indicate that FceRI can be triggered in an analogous manner. Mast cells form a degranulatory synapse upon encountering monovalent, surface-associated ligands (20) , resulting in degranulation in the direction of FceRI signaling (63), which enables a focused, targeted response to pathogens with surfacepresented antigens. Given that basophils and mast cells form stable contacts with T cells and dendritic cells (64) (65) (66) , phosphatase exclusiondependent receptor triggering likely contributes to optimal basophil and mast cell responses in vivo. Our observation of low-level FceRI triggering in cells that made contact with tissue-culture plastic may explain why increased cell adherence correlates with greater sensitivity to antigen (50, 51, 67) and why RBL-2H3 cells grown in suspension have altered protein expression (68) and pharmacological responses (69) compared to those of adherent cells. Signaling in the absence of FceRI ligands may occur alongside, or even amplify, the effects of other factors that increase mast cell activity due to adhesion, including activation of focal adhesion kinase (70) , integrins (51), or receptor tyrosine kinases (71) . Nonetheless, such surface-dependent phosphorylation of FceRI in the absence of ligands appears to be distinct from surface-driven, adhesion-based amplification of FceRI triggering-dependent signaling. Our finding that FceRI triggering is not exclusively dependent on the presence of ligands establishes clear ground between ligand-only theories of signaling and explanations that are not explicitly ligand dependent, such as segregation-based theories.
In this context, it is noteworthy that FceRI seems to form the smallest possible complexes with its ligands. FceRIa comprises a markedly bent structure, such that the IgE-binding domain is located close to the proximal membrane (72) . IgE also forms a curved structure and uses an FceRIa-binding site located next to the hinge region of the antibody, helping to minimize the distance between the mast cell membrane and the IgE Fab regions (55) . These observations suggest that the small size of the complex formed by FceRI with its ligands is important for its function, perhaps because it facilitates phosphatase exclusion. For a triggering system that relied on transphosphorylation, the most efficient structure for FceRI would be one that minimizes its hydrodynamic diameter, enabling the closest approach of neighboring receptors. Simple modeling implies that this would be achieved by FceRI extending directly from the membrane and binding IgE in such a way as to position the Fc orthogonal to the plane of the membrane. However, such a conformation would increase the membrane-Fab separation distance by 5 to 10 nm, likely preventing phosphatase exclusion. FcgRI adopts a similarly bent conformation and binds to the same region of IgG Fc (73) , suggesting that, for this receptor, the dimensions of the ligand-bound complex might also be pivotal. Together, the topological arguments appear to strengthen the case that an evolutionarily conserved, size-dependent, phosphatase exclusion-based mechanism might drive signaling by Fc receptors.
Studies indicating that FcgR signaling in macrophages also depends on CD45 exclusion are conflicting with regard to whether redistribution of the phosphatase is passive (74) or dependent on integrins first forming an actin-tethered diffusional barrier (33). We did not observe any integrin dependence of FceRI signaling. First, neither disrupting integrin activity with a chelating agent nor depletion of CD29, the major integrin b subunit expressed by RBL-2H3 cells, substantially affected FceRI sensitivity to surface-bound ligand. Second, we observed passive CD45 exclusion and receptor triggering in cells interacting with SLBs that presented FceRI ligand mimics and with both LUVs and GUVs. Last, we observed CD45 exclusion in GPMVs that, lacking active cytoskeletons, are incapable of mobilizing any form of actin-tethered diffusional barrier. The chemical and genetic interventions we used have their caveats because CD29 deletion does not globally impair integrin function, and removal of free divalent cations does not physically eliminate integrins from the cell. Nevertheless, the sum of our data argues against there being a strict requirement for integrin mobilization to secure phosphatase exclusion. The findings of Freeman et al. (33) also raise the issue of what is it that "triggers the trigger," that is, integrin activation, enabling FcgR signaling. At the very least, our results suggest that integrin-dependent phosphatase exclusion is not a universal feature of Fc receptor triggering.
Although the case for phosphatase exclusion-based signaling appears to be strong, it also needs to be acknowledged that the role of CD45 in the activation of mast cells is complicated by the fact that it both dephosphorylates ITAMs in activated receptors and activates SFKs by reversing inhibitory phosphorylation at regulatory sites (75) . Despite strenuous efforts to understand the role of CD45 in FceRI signaling, the matter is still incompletely resolved. It has been reported that CD45 is not required for FceRI phosphorylation or Syk activation in response to receptor aggregation (76) , but it is unclear whether this reflects only partial abrogation of SFK activity in the CD45-deficient cells. Cross-linked FceRI is also proposed to be sequestered into ordered membrane domains with higher kinase activity (14) and reduced phosphatase (including CD45) activity, leading to signaling (13) , but other data suggest that rates of dephosphorylation are comparable for receptors in different membrane domains (77) , perhaps because such domains are very short lived (78) . The role of CD45 is therefore very complex, and at present, for example, we cannot rule out the formal possibility that SFKs are activated (through the dephosphorylation of inhibitory tyrosines) in regions abundant in excluded CD45 and that these kinases then diffuse into CD45-depleted areas to promote ligand-dependent and ligand-independent FceRI signaling.
There is also no denying the very potent effects of soluble, multivalent ligands on FceRI-mediated signaling. These types of ligands would not be expected to substantially affect phosphatase distribution per se (consistent with previous observations) (79), except insofar as crosslinking might lead to the formation of clusters of FceRI-IgE-antigen that are too dense to allow passive CD45 entry, which could heighten the sensitivity of FceRI to Lyn. However, even if this is not the case, the two mechanisms need not be mutually exclusive. Aggregation-driven FceRI triggering likely occurs through local increases in kinase (i.e., Lyn) density (12) in a manner analogous to growth factor-induced signaling, which is simply the mirror image of the local exclusion of inhibitory phosphatases. As we have suggested elsewhere (43) , perhaps the common principle is that signaling is achieved no matter how the local balance in kinase and phosphatase activities is perturbed in favor of the kinases.
We propose that an overlap in the triggering mechanisms would enable them to act side by side, maximizing the versatility of FceRI responses to antigens, depending only on their valency and mode of presentation (Fig. 7B) . Some antigens are soluble, multimeric proteins that presumably cannot induce phosphatase exclusion but would be capable of FceRI aggregation. Others may induce responses principally by excluding phosphatases and may be unable to cross-link FceRI. Moreover, some antigens may use both mechanisms if they accumulate into aggregates of a sufficient size that they become an effective surface, for example, large aggregates of cytoskeletal proteins, such as the common helminth allergens tropomyosin and paramyosin (80) . A capacity for phosphatase exclusion-based receptor triggering may increase the scope for polyclonal IgEs to induce robust responses, because some binding geometries unable to efficiently cross-link the receptor might instead exclude phosphatases in the manner of adhesion proteins, also increasing versatility. Which triggering mechanism(s) could dominate in vivo is difficult to predict. An obvious requirement of the phosphatase exclusionbased mechanism is that IgE-targeted antigens should mostly be surface associated. Mast cells respond to surface-bound IgE by forming a secretory synapse in vitro (63) , but it is unclear how commonly surfaceassociated IgE is presented in vivo. Very few protein families (~2%) comprise allergens (80, 81) , and they have no shared structural folds (82) . However, a shared feature of many common allergens is the ability to bind to cell membranes or components of the extracellular matrix. Lipid-binding activity has been observed for many allergens, including members of the largest allergen family, the prolamins (81); the major birch tree pollen antigen, Bet v 1 (83) ; and several of the most potent parasite allergens, for example, the fatty acid-binding nematode polyproteins (84, 85) . Similarly, the principal cat allergen, Fel d 1, shares close homology with uteroglobin (86) , which binds to components of the extracellular matrix (87) and cell membrane (88) , whereas many common helminth allergens, for example, the secreted proteins of Ancylostoma (89, 90) and other venom and allergen-like proteins in a range of species (91, 92) , belong to the cysteine-rich secretory protein family, at least some of which bind to surface ion channels (93) . Onesixth of all known allergens are enzymes with hydrolase activity, including lipases and proteases (81) that, together with the potential to increase antigen exposure through weakening of the epithelial barrier, could conceivably form bridging interactions between FceRI-IgE complexes and physiological surfaces. Examples include dust mite protease allergens that target proteins expressed by human cells (94) and most of the common insect venom antigens, which bind to the extracellular matrix (hyaluronidases) or cell-surface components (phospholipases) (95) . The prevalence of surface-binding allergens suggests that phosphatase exclusion-based signaling could be an important factor in many mast cell and basophil responses. Furthermore, although FceRI is primarily involved in degranulatory responses, it is also a driver of phagocytosis and antibody-dependent cellular cytotoxicity in monocytes (96) , for which the IgE-targeted antigens are all surface associated. The use of IgE in monoclonal antibody therapy has begun to show promise (97) , and for this, as in the case of IgG (74), the size of target antigens may need to be a consideration given the likely requirement for phosphatase exclusion.
S C I E N C E S I G N A L I N G | R E S E A R C H A R T I C L E
Our finding that FceRI is triggered by passive phosphatase exclusion adds to the growing body of evidence that noncatalytic tyrosinephosphorylated receptors (NTRs) might generally be triggered in this way. In other respects, signaling by this class of immune receptors, members of which are usually relatively compact, shares markedly consistent features: Ligand binding induces phosphorylation of the receptors' immunoreceptor tyrosine-based motif(s) by SFKs, enabling recruitment of SH2 domain-containing tyrosine kinases (for activatory receptors) or tyrosine phosphatases (for inhibitory receptors), which propagate the signal (98) . Although best confirmed in the case of the TCR (37, 43) , various NTRs are sensitive to the formation and dimensions of close contacts, including C-type lectins (42), CD28 (99) , and natural killer cell receptors (100, 101), consistent with a shared dependence on size-based, phosphatase exclusion-dependent receptor signaling. The capacity of FceRI to also be triggered by receptor aggregation could be a refinement that enables it to respond to a uniquely broad array of ligands.
MATERIALS AND METHODS
Cell isolation, culture, and handling RBL-2H3 cells (American Type Culture Collection CRL-2256) were cultured at 37°C and 5% CO 2 in Eagle's minimum essential medium (MEM; Sigma-Aldrich) supplemented with 15% FCS, 4 mM L-glutamine, and 1% penicillin-streptomycin-neomycin solution (Sigma-Aldrich). Twenty-four hours before imaging (or for experiments requiring suspension culture), cells were seeded at 1 × 10 6 /ml and incubated in 50-ml culture tubes overnight on an end-over-end rotator (6 rpm) at 37°C. Primary human basophils were isolated from leukocyte cones provided by UK National Health Service Blood and Transplant. Nucleated cells were separated from erythrocytes with the HetaSep aggregation agent (STEMCELL Technologies) as per the manufacturer's instructions. Basophils were isolated through negative selection with the EasySep Human Basophil Enrichment Kit (STEMCELL Technologies) and used immediately after isolation.
Cloning and stable expression of fluorescent constructs Rat FceR1a was amplified from complementary DNA (cDNA) prepared from total RBL-2H3 cell RNA using the oligonucleotide primers
and 5′-CTACTAGGTACCGCCACTCC-CACCTTTTTTTTTGCCTTTTCCAGTC-3′ and subcloned into the lentiviral pHR vector upstream of a SNAP-tag-encoding sequence. The resultant construct contained a flexible Gly-Ser-Gly sequence between FceR1a and SNAP-tag. Syk-citrine was also generated in pHR by amplification of rat Syk from RBL-2H3 cDNA using the primers 5′-TAGTAGACGCGTGCCACCATGGCGGGCAATGCTGTGGA-CAATG-3′ and 5′-CTACTAGGATCCCCGTTAACCACGTCG-TAGTAGTAATTG-3′ and subcloned upstream of the citrine sequence. Rat CD45 was amplified from RBL-2H3 cDNA using the primers 5′-TAGTAGACGCGTGCCACCATGTATTTGTGGCT-CAAACTTCTGGCC-3′ and 5′-CTACTAGGTACCCCT-GAGCTCGGGGTTAGAGCTGGGC-3′, which was subcloned into pHR upstream of the HaloTag sequence. For the chimeric CD86CD45 and CD43CD45 forms, the transmembrane-and intracellular domainencoding segments of rCD45 were amplified using the primers 5′-CCTCCCCCAGACCACGCACTGATTATATTCC-3′ or 5′-GA-GAACTCACGAGGCGCACTGATTATATTCC-3′, respectively, to enable overlap with the extracellular domain-encoding segments of hCD86 and hCD43 amplified from cDNA prepared from RNA extracted from human THP-1 cells with the primers 5′-TAGTA-GACGCGTGCCACCATGGATCCCCAGTGCACTATG-3′ and 5′-GGAATATAATCAGTGCGTGGTCTGGGGGAGG-3′ (for CD86) or 5′-TAGTAGACGCGTGCCACCATGGCCACGCTTCTCCTTCTCC-3′ and 5′-GGAATATAATCAGTGCGCCTCGTGAGTTCTC-3′ (for CD43). These fragments were used in chimeric polymerase chain reactions to generate the full-length constructs, which were then inserted into pHR upstream of HaloTag. For all fluorescent constructs, human embryonic kidney (HEK) 293 cells were cotransfected with pHR vectors and with pMD.G and p8.91 with GeneJuice (Novagen) as per the manufacturer's instructions. Harvested lentivirus was incubated with RBL-2H3 cells in culture for 72 hours before expression of the relevant proteins was assessed by flow cytometry. A pure population of cells expressing all constructs was then derived by fluorescence-activated cell sorting.
Cloning and purification of His-rFce fragments
The sequence encoding rat IgE heavy chain domains C H 2 to C H 4 were amplified from cDNA prepared from total rat spleen RNA using the oligonucleotide primers 5′-TAGTAGGTTTAAACTCGGA-GGCGCTCGACCTGTCAACATCACCAAGCC-3′ and 5′-CTAC-TAGAATTCCTACATGGAGGCCTGGGAGGGACGG-3′. For the short His-rFce form, this was inserted into the pOPINEE12G vector immediately after a sequence encoding the tag N-HHHHHHS-RAWRHPQFGGHHHHHH-C. The construct also encoded a heterologous secretory signal peptide (MGILPSPGMPALLSLVSLLS-VLLMGCVAE) directly upstream of the His-tag. For the CD43 1 and CD43 3 forms, the sequence encoding the extracellular domain of hCD43 after the native signal peptide (residues 20 to 254) was inserted either once or in three tandem repeats separated by restriction sites for Kpn I, Xho I, and Pme I. The pOPINEE12G vectors were used to transfect Chinese hamster ovary K1 cells, which were then enriched through glutamine synthetase selection. Dilution-plated clones were assessed for expression of secreted protein by Western blotting analysis of their culture medium with anti-His 5 , and those clones with the best expression were moved to large culture. Cells were cultured in T175 tissue culture flasks in the presence of 2 mM sodium butyrate for 2 weeks before the cell culture medium was harvested and extraction of the His-tagged protein was performed with Ni-nitrilotriacetic acid (NTA) agarose beads (Qiagen). Extracted protein was cleaned by fast protein liquid chromatography on a Superose 6 10/300 column (GE Healthcare) and ÄKTA pure system (GE Healthcare). Samples of the proteins were labeled using the Alexa Fluor 647 antibody labeling kit (Thermo Fisher Scientific) as per the manufacturer's instructions for use in flow cytometry experiments.
CRISPR-Cas9 knockout of FceRIa
Genomic knockout of FceRIa from RBL-2H3 cells was performed with the lentiCRISPR v2.0 (Addgene plasmid #52961) system (102), which was a gift from F. Zhang (Massachusetts Institute of Technology). The guide sequence 5′-ATTACACAATTGAGTATCGT-3′ was ligated into the vector using Bsm BI restriction sites. This sequence targets nucleotides 584 to 603 of rat FceR1a, corresponding to residues 196 to 201 of the translated protein, and has a fidelity score of 85 as determined by the CRISPR design tool (https://zlab.bio/guide-design-resources). Lentiviral particles containing this vector sequence were generated by cotransfection of HEK 293T cells with lentiCRISPR v2.0 and with pMD.G and p8.91 using GeneJuice (Novagen) as per the manufacturer's instructions. Harvested lentivirus was incubated with RBL-2H3 cells in culture for 5 days before the cell surface expression of FceRIa was assessed by flow cytometry analysis of cells stained with Alexa Fluor 647-conjugated mouse IgE. A pure FceRI−ve population was then derived by fluorescence-activated cell sorting. To obtain an FceRIrestored (FceRI+ve) RBL-2H3 line, a CRISPR-resistant FceRIa mutant was generated by site-directed mutagenesis of the target sequence to 5′-AcTAtACgATcGAaTAcCGg-3′ (mutations in lowercase), which translates to the same protein sequence as that encoded by the WT gene. The mutant FceRIa gene was inserted into the lentiviral pHR vector and used to transduce FceRI−ve RBL-2H3 cells as described earlier. As before, FceRIa cell surface expression was assessed by flow cytometry, and a pure FceRI+ve RBL-2H3 population of cells was obtained by cell sorting.
CRISPR-Cas9 knockout of CD29 CD29−ve RBL-2H3 cells were generated in the same manner as that described for the FceRI−ve RBL-2H3 cell line but using the guide sequence 5′-TCATCACATCGTGCAGAAGT-3′, which targets nucleotides 178 to 197 of rat Itgb1. This sequence has a fidelity score of 75 (https://zlab.bio/guide-design-resources). A pure population of cells was sorted by staining with fluorescein isothiocyanate (FITC)-conjugated hamster anti-rat CD29 (BioLegend, catalog no. 102205).
Flow cytometry
In all cases, cells were labeled with antibody/protein at 1 mg/ml in PBS and 0.05% sodium azide for 1 hour at 4°C. Cells were washed three times with 4 ml of cold PBS-azide before resuspension in 400 ml of PBS-azide. Fluorescence was measured with a CyAn ADP flow cytometer (Beckman Coulter). To assess cell surface integrin expression, FITC-conjugated hamster anti-rat CD29 (BioLegend, catalog no. 102205) and FITC-conjugated mouse anti-rat CD49d (BioLegend, catalog no. 200103) were used. For general rFceRI staining, mouse anti-TNP IgE conjugated to Alexa Fluor 647 was used. Primary human basophils were stained with anti-CD123 FITC (BioLegend, catalog no. 306005) and anti-hIgE APC (BioLegend, catalog no. 325507). To assess Fce construct binding, RBL-2H3 cells were stained with the relevant Alexa Fluor 647-labeled protein, washed, and then incubated at 37°C in 4 ml of PBS-azide for various times after washing to enable dissociation of Fce. Cells were then pelleted and resuspended in 400 ml of PBS-azide before analysis.
Preparation of activating surfaces
For all imaging experiments, glass-bottom chambers (World Precision Instruments, FD3510) were used for coating, whereas Western blotting experiments were performed in coated plastic 24-well tissue culture plates. For TNP BSA -IgE coating, surfaces were incubated with 200 ml of TNP-conjugated BSA (TNP BSA ; 50 mg/ml) (Insight Biotechnology) in coating buffer [50 mM Na 2 CO 3 and 50 mM NaHCO 3 (pH 9.6)] overnight at 4°C. The chambers were washed three times with 200 ml of PBS before 200 ml of mouse anti-TNP IgE (5 mg/ml, unless otherwise specified; BD Biosciences, catalog no. 554118) in PBS was added to the chamber and incubated at 4°C for 2 hours. Chambers were then washed three times with 200 ml of PBS and covered with 200 ml for PBS for experiments. For PLL coating, surfaces were incubated with 200 ml of 0.01% PLL for 30 min at room temperature and then washed three times with 200 ml of PBS before use. For laminin peptide coating, surfaces were coated with 200 ml of rat laminin peptide (150 mg/ml; Merck Millipore, catalog no. SCR127) and TNP BSA in coating buffer (50 mg/ml) overnight at 4°C. Chambers were washed and coated with IgE as described earlier. For Der f 1 coating, surfaces were coated with 200 ml of purified Der f 1 (50 mg/ml; Indoor Biotechnologies, catalog no. NA-DF1-2) in coating buffer overnight at 4°C and washed three times with 200 ml of PBS before use. Before they were stimulated on these surfaces, primary basophils were loaded with human anti-Der f 1 IgE (1 mg/ml; Absolute Antibody, Ab00132-14.0) for 10 min and then washed three times with PBS. For anti-IgE coating, surfaces were coated with either 200 ml of mouse anti-hIgE (50 mg/ml; BioLegend, catalog no. 325507) or donkey anti-mouse IgG (50 mg/ml; Stratech, 715-001-003 JIR) in coating buffer overnight at 4°C. Surfaces were washed three times with 200 ml of PBS, and then, the donkey antimouse-coated surfaces were incubated with mouse anti-hIgE (5 mg/ml) for 2 hours at room temperature before washing three times with 200 ml of PBS. Coating efficiency was determined with anti-hIgE labeled with the Alexa Fluor 647 antibody labeling kit (Thermo Fisher Scientific) as per the manufacturer's instructions, with fluorescence intensity at the coverslip surface measured with a Zeiss LSM 780. SLBs were prepared as described previously (37) . Briefly, glass slides were cleaned with piranha solution. Lipid mix [1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC):nickelated lipid, 96:4; 1 mg/ml] was deposited on the glass slides on a spin coater at 3000 rpm for 30 s and hydrated in Hepesbuffered saline (HBS). His-Fce (1 mg/ml) or equimolar equivalents of other Fce chimeras were coated and washed as described previously (37) . Ni-coated glass coverslips (Nanocs, catalog no. CS-NTA-5) were coated with His-Fce (1 mg/ml) or equimolar equivalents of other Fce chimeras for 30 min before being washed three times with 500 ml of PBS. Coverslips were then blocked with 5% BSA for 30 min and washed three times with 500 ml of PBS.
Preparation of GPMVs
GPMVs were prepared as described previously (46) . Briefly, RBL-2H3 cells were grown in 35-mm plastic cell culture petri dishes. Before GPMV preparation, cells were labeled with HaloTag and SNAP-tag probes and then washed twice with GPMV buffer [10 mM Hepes, 150 NaCl, and 2 mM CaCl 2 (pH 7.4)] and incubated for 1 hour in GPMV buffer containing 2 mM dithiothreitol and 25 mM paraformaldehyde at 37°C. GPMVs were then imaged on activating surfaces as described earlier.
Preparation of GUVs and LUVs
GUVs were prepared through an electroformation method. Lipid mixture (POPC:nickelated lipid, 96:4 molar ratio; 1 mg/ml) was deposited on a platinum wire and dried. The wire was then dipped into a Teflon-coated chamber filled with 300 mM sucrose. GUV formation was triggered by applying a 10-Hz AC field for 1 hour, which was followed by the application of a 2-Hz AC field for 30 min. After GUV formation, 100 ml of the GUV suspension was incubated with His-tagged protein (1 mg/ml) for 30 min. To wash out any unbound protein, the GUV mixture was gently mixed with 1 ml of PBS and allowed to sediment for 30 min. The bottom 100-ml fraction was transferred to a new tube containing 1 ml of PBS. This process was repeated twice. GUVs were imaged in PBS as described earlier. To prepare LUVs, 50 ml of a lipid mix (POPC:nickelated lipid, 96:4 with 0.001 mole percent laurdan; 1 mg/ml) was dried in a glass vial under N 2 flow. Next, 200 ml of HBS was added to the dried lipid film, which was then vortexed for 20 s. The suspension was then sonicated for 20 min, and the LUVs were loaded in the same manner as described for GUVs.
Cell labeling
Cells were incubated with TMR-HaloTag ligand and SiR-SNAP-tag ligand (each at a final concentration of 0.5 mM) at 37°C for 30 min. Cells were then washed twice with fresh prewarmed medium supplemented with FCS by centrifugation (500g for 2 min) and were incubated in fresh full medium at 37°C for 30 min to remove unbound fluorescent ligands. Last, the cells were washed twice by centrifugation (500g for 2 min) and resuspended in imaging medium.
Confocal and IRM imaging
Confocal images were acquired using a Zeiss LSM 780. Labeled cells were excited at 488, 561, and 633 nm for citrine, the TMR-HaloTag ligand, and the SiR-SNAP-tag ligand, respectively. All channels were acquired with different tracks to eliminate cross-talk. A 40× objective [numerical aperture (NA), 1.2] was used to acquire images. IRM images were obtained using the same instrument with a 488-nm laser line for excitation and 470 to 505 nm for detection in the transmission channel. Values for individual cell surface areas were determined from IRM images by measuring the number of pixels corresponding to thresholded images of each cell using the tracing tool in the ImageJ software. This was converted to square micrometers by reference to pixel size.
Fluorescence correlation spectroscopy FCS was measured using a 40× objective (NA, 1.2) on a Zeiss LSM 780. A diffraction-limited spot was focused on the basal or apical plane of the cells, and three measurements for 10 s each were taken on each point. We measured a minimum of 10 cells for each condition. The autocorrelation functions were fitted with a 2D + Triplet model to obtain the transit diffusion time and the number of particles.
Ca
2+ imaging RBL-2H3 cells were labeled with 4 mM Fluo-4 for 30 min at room temperature in RPMI 1640 with no supplement. Cells were then washed in PBS and resuspended at~1 × 10 6 cells/ml in PBS. A cell suspension (50 ml) was gently added to the 200 ml of solution on imaging coverslips, and image collection was begun immediately. Cells were imaged with a 10× objective (NA, 0.45) on a Zeiss spinning disk confocal microscope with 488-nm laser excitation for 600 frames at 1 frame/s and an exposure time of 800 ms. All imaging was performed inside a heated cabinet at 37°C, and coverslips, cells, and solutions were allowed to equilibrate to 37°C before imaging. Ca 2+ images were analyzed with CalQuo software (103) , generating a triggering fraction value for each video and a triggering frame value for each triggered cell. For experiments with PP2-treated or divalent cation-free samples, cells were labeled with Fluo-4 as described earlier and resuspended in either PBS containing 10 mM PP2 or Mg 2+ /Ca 2+ -free PBS containing 1.5 mM EDTA. The solution used on the coverslip was the same as that used for cell treatment (that is, +PP2/EDTA). For experiments using a soluble ligand, RBL-2H3 cells were plated onto glass coverslips at~1 × 10 5 /ml and cultured for 24 hours to obtain adherent cells. Cells were washed with PBS, labeled with Fluo-4, and washed as described earlier before being covered with 200 ml of PBS containing anti-TNP IgE (0.1 mg/ml) at 37°C for 10 min. Cells were washed three times with 200 ml of PBS, and image acquisition was begun. At 20 frames (20 s), 20 ml of TNP BSA in PBS (1 mg/ml) was added to give a final concentration of 100 ng/ml.
Cell stimulation and Western blotting analysis
Cells were treated with either 10 mM PP2 or 10 mM pervanadate for 15 min at room temperature or with PP2 for 15 min and then pervanadate for 15 min, or vice versa. Pervanadate was freshly prepared using 1 mM sodium orthovanadate and 0.3% hydrogen peroxide in 20 mM Hepes for 5 min before neutralization with bovine catalase. Stimulation of RBL-2H3 cells by a soluble ligand was performed by incubation with anti-TNP IgE (1 mg/ml) for 15 min at room temperature, before washing and incubating with TNP BSA (100 ng/ml) for 15 min at room temperature. Primary basophils were stimulated in solution using mouse anti-hIgE (0.5 mg/ml). Cells stimulated on surfaces were allowed to settle at room temperature for various times before solubilization. After stimulation, 0.5 × 10 6 cells in 100 ml of PBS were solubilized for 20 min on ice by the addition of 10 ml of 10× radioimmunoprecipitation assay buffer (Cell Signaling Technology) supplemented with 20 mM sodium orthovanadate, 30 mM EDTA-free protease inhibitors (Sigma-Aldrich, catalog no. 4693132001), and 1% protease inhibitor cocktail (Sigma-Aldrich, catalog no. P5726). Solubilized samples were centrifuged at 14,000g for 5 min to remove protein aggregates, diluted in 4× SDS protein loading buffer with 10% b-mercaptoethanol, and separated on mini-PROTEAN TGX polyacrylamide gels (Bio-Rad). Proteins were transferred to nitrocellulose membrane, blocked with Odyssey blocking buffer (LI-COR Biosciences) for 3 hours, and then incubated with rabbit anti-FceRIg (Merck-Millipore, P06727) and mouse phospho-specific anti-FceRIg antibodies (34) , provided by R. Suzuki (Nagoya City University, Japan). Donkey antirabbit IRDye 680RD (LI-COR Biosciences) and donkey anti-mouse IRDye 800CW (LI-COR Biosciences) secondary antibodies were used to enable simultaneous imaging and quantification in both channels using a LI-COR Biosciences Odyssey CLx infrared imaging system. In all experiments, a soluble triggered sample was included for normalization. All data were normalized to this value using the following equation ) were allowed to settle onto activating or nonactivating surfaces in a total volume of 100 ml of Hepes buffer (10 mM Hepes, 137 mM NaCl, 2.7 mM KCl, 0.4 mM Na 2 HPO 4 ·7H 2 O, 5.6 mM glucose, 1.3 mM MgSO 4 ·7H 2 O, and 0.04% BSA) for 30 min at 37°C without CO 2 . A sample of supernatant (75 ml) was removed and centrifuged at 11,000g for 1 min in a 1.5-ml tube to remove any cells. Of this, 50 ml was then transferred to a well of a transparent, flat-bottomed 96-well plate. Negative control wells containing only Hepes buffer were also plated. We then added 100 ml of p-nitrophenyl N-acetyl-b-D-glucosamide (3.5 mg/ml in 40 mM citric acid) and 20 mM Na 2 HPO 4 ·7H 2 O (pH 4.5) to each well and incubated the samples for 90 min at 37°C without CO 2 . The reaction was stopped after 90 min by the addition of 50 ml of 400 mM glycine (pH 10.7). Absorbance at 405 nm was measured using a SPECTROstar Nano plate reader. Background was established relative to the wells containing Hepes buffer alone. The percentage degranulation was calculated by reference to the absorbance at 405 nm of RBL-2H3 cells solubilized with 0.1% Triton X-100, which was defined as 100%.
Measurement of cell adhesion and dendricity
Cell adhesion was measured as a function of the mechanical force required to detach cells from a cultured plastic surface. RBL-2H3 cells were plated at 3 × 10 5 cells per well in a plastic six-well plate in supplemented MEM and incubated for 24 hours. Medium containing any nonadherent cells was removed, and the adherent cells were washed with 1 ml of PBS. Cells were then covered with 2 ml of PBS and placed onto a benchtop orbital shaker at varying speeds for 30 min at room temperature. After shaking, the number of detached cells in solution was counted using a hemocytometer. The remaining adherent cells were detached by incubation with trypsin and EDTA for 10 min and counted in the same manner. Spontaneous growth in suspension was determined by plating the RBL-2H3 cells at 3 × 10 5 cells per well in a plastic six-well plate in supplemented MEM and incubating them for 24 to 72 hours before assessing the suspension and adherent fractions as described earlier. Cell dendricity was determined by collecting differential interference contrast (DiC) images of RBL-2H3 cell populations cultured on glass coverslips for 24 hours after plating at 3 × 10 5 cells/ml. Cells were qualitatively classed as dendritic if they exhibited protruding dendrites from the main cell body, whereas those cells with roughly spherical morphologies were classed as nondendritic.
Statistical analysis
All statistical analysis was performed using GraphPad Prism 7.0a software. Datasets were assessed for statistically significant differences using an unpaired two-tailed t test. For comparisons of values from individual cells (cell contact area, time to triggering, and FCS data), data from all cells were pooled before analysis. For all others, an individual value was determined for each independent experiment (for example, percentage of cells triggered), and these were pooled for analysis.
SUPPLEMENTARY MATERIALS
www.sciencesignaling.org/cgi/content/full/11/561/eaat0756/DC1 Fig. S1 . FceRI-negative RBL-2H3 cells move like WT cells, and PLL leads to FceRIg phosphorylation in RBL-2H3 cells and primary basophils. Fig. S2 . Equivalent FceRI-dependent binding is exhibited by all Fce-containing ligands used for RBL-2H3 cell activation, and FceRIg phosphorylation in primary basophils is regulated by the global kinase-phosphatase balance. Fig. S3 . Additional examples of CD45 exclusion from the basal planes of RBL-2H3 cells on ligand-presenting surfaces. Fig. S4 . Syk is recruited to FceRI bound to surface-associated ligand, and robust CD45 exclusion in primary basophils requires specific IgE-ligand interactions. Fig. S5 . CD45 exclusion is a passive process. 
